Abstract:Background: Previous studies focused more on the short-term risk of cardiovascular (CV) death due to traumatic psychological stress after a cancer diagnosis and the acute cardiotoxicity of anticancer treatments than on the long-term risk of CV death. Methods: Time trends in the proportions of CV death (P CV ), cancer death (P CA ), and other causes in deaths from all causes were used to show preliminary relationships among the three causes of death in 4,806,064 patients with cancer from the Surveillance, Epidemiology, and End Results (SEER) program. Competing mortality risk curves were used to investigate when the cumulative CV mortality rate (CMR CV ) began to outweigh the cumulative cancer mortality rate (CMR CA ) for patients with cancer who survived for more than 10 years. Multivariable competing risk models were further used to investigate the potential factors associated with CV death. Results: For patients with cancer at all sites, the P CV increased from 22.8% in the 5th year after diagnosis to 31.0% in the 10th year and 35.7% in the 20th year, while the P CA decreased from 57.7% in the 5th year after diagnosis to 41.2 and 29.9% in the 10th year and 20th year, respectively. The P CV outweighed the P CA (34.6% vs. 34.1%) since the 15th year for patients with cancer at all sites, as early as the 9th year for patients with colorectal cancer (37.5% vs. 33.2%) and as late as the 22nd year for patients with breast cancer (33.5% vs. 30.6%). The CMR CV outweighed the CMR CA since the 25th year from diagnosis. Multivariate competing risk models showed that an increased risk of CV death was independently associated with older age at diagnosis [hazard ratio and 95% confidence intervals [HR (95%CI)] of 43.39 (21.33, 88.28) for ≥ 80 vs. ≤ 30 years] and local metastasis [1.07 (1.04, 1.10)] and a decreased risk among women [0.82 (0.76, 0.88)], surgery [0.90 (0.87, 0.94)], and chemotherapy [0.85 (0.81, 0.90)] among patients with cancer who survived for more than 10 years. Further analyses of patients with cancer who survived for more than 20 years and sensitivity analyses by cancer at all sites showed similar results. Conclusion: CV death gradually outweighs cancer death as survival time increases for most patients with cancer. Both the cardio-oncologist and cardio-oncology care should be involved to reduce CV deaths in long-term cancer survivors.

Cardiovascular-specific Mortality and Risk Factors in Colorectal Cancer Patients: A Cohort Study Based on Registry Data of over 500,000 Individuals in the US.

A Retrospective Clinical Study on Cardiovascular Complications from Colorectal Cancer

A population-based study of cardiovascular disease mortality risk in US cancer patients

Cardiovascular death risk in patients with solid tumors: a population-based study in the United States

Higher risk of cardiovascular mortality than cancer mortality among long-term cancer survivors

Cardiovascular Mortality in Patients with Gynecological Cancers: A Population-based Cohort Study

Lung cancer and Risk of Cardiovascular Mortality

Nomogram predicting the cardiovascular disease mortality for older patients with colorectal cancer: A real-world population-based study

Risk factors of death from vascular events among cancer survivors: A SEER database analysis

Association Between Cardiovascular Risk Factors and Colorectal Cancer: A Systematic Review and Meta-Analysis of Prospective Cohort Studies

National and Subnational Incidence, Mortality and Associated Factors of Colorectal Cancer in China: A Systematic Analysis and Modelling Study.

Cause of Death for Elders with Colorectal Cancer: a Real-World Data Analysis.

Cardiovascular mortality in people with cancer compared to the general population: A systematic review and meta-analysis

Survival and cardiovascular disease mortality among primary liver cancer patients: A population-based study

Association Between Radiotherapy and Death From Cardiovascular Disease Among Patients With Cancer: A Large Population‐Based Cohort Study

Predicting the probability of death within five years after surgery in patients with colorectal cancer

Impact of PAMAM delivery systems on signal transduction pathways in vivo: Modulation of ERK1/2 and p38 MAP kinase signaling in the normal and diabetic kidney.

Long-term risks of cardiovascular death among older patients with major hematological malignancies: a population-based cohort study from SEER database

Cause-Specific Mortality Among Survivors From T1N0M0 Renal Cell Carcinoma: A Registry-Based Cohort Study

The interaction between the catalytic A subunit of calcineurin and its autoinhibitory domain, in the yeast two‐hybrid system, is disrupted by cyclosporin A and FK506

Increased incidence risks of cardiovascular disease among cancer patients: Evidence from a population-based cohort study in China